Reticular

San Francisco, United States

Reticular is an AI based Biotechnology Research firm that discover bilogical drugs with limited data.

$500K raised

Dec 2024

Pre-Seed

Top Investors

Y Combinator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Reticular raised?

Reticular has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.

Who are Reticular's investors?

Reticular's investors include Y Combinator.

Where is Reticular headquartered?

Reticular is headquartered in San Francisco, United States.

What does Reticular do?

Reticular is an AI based Biotechnology Research firm that discover bilogical drugs with limited data.

What stage is Reticular at?

Reticular is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2024.

MLA

"Reticular — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/reticular. Accessed June 17, 2026.

APA

VCBacked. (2024). Reticular — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/reticular

Wikipedia (cite web)

{{cite web |title=Reticular — Funding & Investors |url=https://www.vcbacked.co/company/reticular |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2024.